Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Johnson

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Neuropharmacology|November 15, 2000
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic painK Walker, M Bowes, M Panesar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5M A Varney, N D Cosford, C Jachec, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1996
Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edemaM W Eldridge, A Podolsky, R S Richardson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1996
Exercise-induced VA/Q inequality in subjects with prior high-altitude pulmonary edemaA Podolsky, M W Eldridge, R S Richardson, et al.
Lancet (London, England)|October 7, 1997
New variant Creutzfeldt-Jakob disease: psychiatric featuresM Zeidler, E C Johnstone, R W Bamber, et al.
Journal of Neurochemistry|November 3, 1998
The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expressionL P Daggett, E C Johnson, M A Varney, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivoF Gasparini, V Bruno, G Battaglia, et al.
Pathogens and Disease|July 20, 2021
Intentional mentoring: maximizing the impact of underrepresented future scientists in the 21st centuryHaysetta Shuler, Victor Cazares, Andrea Marshall, et al.
Neuropharmacology|October 26, 1999
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonistF Gasparini, K Lingenhöhl, N Stoehr, et al.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Neuropharmacology|November 15, 2000
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic painK Walker, M Bowes, M Panesar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5M A Varney, N D Cosford, C Jachec, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1996
Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edemaM W Eldridge, A Podolsky, R S Richardson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1996
Exercise-induced VA/Q inequality in subjects with prior high-altitude pulmonary edemaA Podolsky, M W Eldridge, R S Richardson, et al.
Lancet (London, England)|October 7, 1997
New variant Creutzfeldt-Jakob disease: psychiatric featuresM Zeidler, E C Johnstone, R W Bamber, et al.
Journal of Neurochemistry|November 3, 1998
The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expressionL P Daggett, E C Johnson, M A Varney, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivoF Gasparini, V Bruno, G Battaglia, et al.
Pathogens and Disease|July 20, 2021
Intentional mentoring: maximizing the impact of underrepresented future scientists in the 21st centuryHaysetta Shuler, Victor Cazares, Andrea Marshall, et al.
Neuropharmacology|October 26, 1999
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonistF Gasparini, K Lingenhöhl, N Stoehr, et al.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Pageof 10